Skip to Main Content

Paper Details

A serological assay to detect SARS-CoV-2 seroconversion in humans.
medRxiv
115
2020
COVID 19, COVID19, CoV, CoV-2 antibodies, Coronavirus Disease 2019, Cov-2 antibody, SARS, SARS-, SARS-CoV-2, SARS-Cov-2, health care workers, human, human plasma, humans, patients, serum, severe acute respiratory disease coronavirus, severe acute respiratory disease coronavirus 2, spike protein, viral genetic
Author NameAffiliation
Teresa AydilloIcahn School of Medicine at Mount Sinai
Lisa MiorinIcahn School of Medicine at Mount Sinai
Erna Milunka KojicIcahn School of Medicine at Mount Sinai
Charlotte Cunningham-RundlesIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreGlobal Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
Viviana SimonGlobal Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 9

Datasets

Release 1.2